Evidence map›Paper›PMID 37452871›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2023

Comparison of 99mTc radiolabeled somatostatin antagonist with [

Marta Opalinska, Luka Lezaic, Clemens Decristoforo, Petra Kolenc, Renata Mikolajczak, Andrej Studen, Urban Simoncic, Irene Virgolini, Malgorzata Trofimiuk-Muldner, Piotr Garnuszek and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Marta OpalinskaChair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland.
Luka LezaicDepartment of Nuclear Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Clemens DecristoforoDepartment of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.
Petra KolencDepartment of Nuclear Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Renata MikolajczakRadioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Poland.
Andrej StudenFaculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia.
Urban SimoncicFaculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia.
Irene VirgoliniDepartment of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.
Malgorzata Trofimiuk-MuldnerChair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland.
Piotr GarnuszekRadioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Poland.
Christine RanggerDepartment of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.
Melpomeni FaniUniversitätsspital Basel, Basel, Switzerland.
Boguslaw GlowaUniversity Hospital Krakow, Krakow, Poland.
Konrad SkorkiewiczUniversity Hospital Krakow, Krakow, Poland.
Alicja Hubalewska-DydejczykChair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland. alahub@cm-uj.krakow.pl.ORCID 0000-0001-5208-4689

Funding

Austrian Science Fund FWF I 4220
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Neuroendocrine TumorsOrganometallic CompoundsHeterocyclic Compounds, 1-RingHumansReceptors, SomatostatinSomatostatin1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidHeterocyclic Compounds, 1-RingOrganometallic CompoundsReceptors, SomatostatinSomatostatin

Identifiers

PMID37452871
PMCPMC10611881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.